An executive shuffle at Conmed Corp. is unlikely to impact day-to-day operations at ConMed Linvatec, the largest medical technology company in Tampa Bay. An executive shuffle at Conmed Corp. is ...

CONMED Corporation CNMD is well-positioned for growth on the back of rising adoption of its high-margin, differentiated platforms like AirSeal, Buffalo Filter and BioBrace. The company’s long-term ...

CONMED Corporation CNMD delivered adjusted earnings per share (EPS) of $1.08 in the third quarter of 2025, up 2.9% year over year. The figure beat the Zacks Consensus Estimate by 2.9%. The adjustments ...

The CEO is out at ConMed Corp., the parent company of the largest medical technology firm in Tampa Bay. The CEO is out at ConMed Corp., the parent company of the largest medical technology firm in ...

Medical tech company CONMED (NYSE:CNMD) announced in Q3 CY2025, with sales up 6.7% year on year to $337.9 million. The company expects the full year’s revenue to be around $1.37 billion, close to ...

CONMED Corporation CNMD announced that it has completed the acquisition of privately-held start-up, Biorez, in an all-cash deal worth $85 million. The company had signed a definitive agreement earlier ...

The multi-year agreements are with CONMED’s Linvatec and Endoscopic Technologies. Products covered in the agreements include CONMED’s advanced endoscopic imaging products, Enteral Feeding systems and ...

We came across a bullish thesis on CONMED Corporation on DeepValue Capital’s Substack. In this article, we will summarize the bulls’ thesis on CNMD. CONMED Corporation’s share was trading at $46.00 as ...